Absent virtues: The poacher becomes gamekeeper

Journal of Medical Ethics

Volumn 29, Issue 6, 2003, Pages 337-342

  Koch, T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; LEGAL LIABILITY; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL PROFESSION; NORTH AMERICA; PATERNALISM; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD;

ANALYTICAL APPROACH; BIOETHICS AND PROFESSIONAL ETHICS;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; BIOETHICAL ISSUES; DECISION MAKING; DRUG INDUSTRY; ETHICS, MEDICAL; ETHICS, RESEARCH; HUMANS; MORALS; PERSONAL AUTONOMY; PHYSICIAN-PATIENT RELATIONS; SOCIAL RESPONSIBILITY; TISSUE AND ORGAN PROCUREMENT; TRUTH DISCLOSURE; UNITED STATES;

EID: 0347527072     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.29.6.337     Document Type: Article

References (48)

1. Jones AR. The birth of bioethics. Hastings Cent Rep 1998;23:S5.
2. Pellegrino ED. The metamorphosis of medical ethics: a 30 year perspective. JAMA 1993;269:1158-62.
3. Binmore K. Just playing: game theory and the social contract II. Cambridge: MIT Press, 1998:511.
4. Beauchamp TL, Childress JF. Principles of biomedical ethics. [4th ed]. NY: Oxford University Press, 1994.
5. Thomasma DC. Bioethics and international human rights. J Law Med Ethics 1997;25:295-306.
6. Koch T. The limits of principle: deciding who lives and what dies. Westport, CT, and London: Praeger Books, 1998.
7. Lowry EH. Of health care professionals, ethics, and strikes. Camb Q Healthc Ethics 2000;9:513-20.
8. Baylis F. Heroes in bioethics. Hastings Cent Rep 2000;31:34-9.
9. Sandstrom E. Medical agencies fear drop in organ donations. Beacon Journal (Akron) 1997 Apr 9:A1.
10. Kolata G. Controversy erupts over organ removals. The New York Times 1997 Apr 13;Sect 1, 28.
11. Agich G. From Pittsburgh to Cleveland: NHBD controversies and bioethics. Camb Q Healthc Ethics 1999;8:269-74.
12. Waithe ME. Blowing the whistle on transplant protocol [letter]. Cleveland Plain Dealer 1997 May 21:13.
13. National Organ Transplant Act (NOTA). Pub I no 98-507; 98 stat 2339 1984.
14. McCurdy DB. Disclosure v confidentiality: When disaster strikes. Making the Rounds in Health, Faith, & Ethics 1996;1:1-5.
15. Spielman B, Verhulst S. Non-heartbeating cadaver procurement and the work of ethics committees. Camb Q Healthc Ethics 1997;6:282-7.
16. Fisher J. Re-examining death: against a higher brain criterion. J Med Ethics 1999;25:473-6.
17. Truog RD. Is it time to abandon brain death? Hastings Cent Rep 1997;17:27-31.
18. Koch T. Scarce goods: justice, fairness, and organ transplantation. Westport CT and London: Praeger Publishing, 2002.
19. Niewijk A. Tough priorities: organ triage and the legacy of apartheid. Hastings Cent Rep 1999;29:42-50.
20. Sheper-Hughes N. The global traffic in human organs. Curr Anthropol 2000;41:191-225.
21. Mandel M. Nancy and Goliath/sick kids' doctors' battle with drug giant is anything but black and white. Ottawa Sun 1998 Dec 7:8.
22. Olivieri NF, Brittenham GM, Mclaren CE, et al. Long term safety and effectiveness of iron chelation therapy with Deferiprone for thalassaemia major. N Engl J Med 1998;339:417-23.
23. Anon. Drug risk revealed. Toronto Sun 1998 Aug 14:50.
24. Anon. Researcher strikes back. Winnipeg Sun 1998 Dec 11:13.
25. Anon. MDs push drug probe. Winnipeg Sun 1998 Aug 18:12.
26. Chapman D. Hospital admits errors/sick kids: says it backs researcher but Toronto Sun 1998 Dec 11:60.
27. Brittenham GM, Fleming KA, Olivieri N. Iron chelation with oral Deferiprone in patients with thalassaemia [letter]. N Engl J Med 1998;339:1710-14.
28. Savulescu J. Harm, ethics committees, and the gene therapy death [editorial]. J Med Ethics 2001;27:148-50.
29. Savulescu J, Spriggs M. The hexamethonium asthma study and the death of a normal volunteer in research. J Med Ethics 2002;28:3-4.
30. Recer P. Accusations in gene therapy death. Associated Press, http://www.dialog.com/APNES (accessed 2 Feb 2002).
31. Elliott C. Pharma buys a conscience. The American Prospect 2001 Sept 24. http://www.prospect.org/print/V12/17/elliott-c.html (accessed 27 Mar 2002).
32. R v Latimer (1994) 124 Saskatchewan R 9, 19-59.
33. R v Latimer (1995), 99 CCC (3d) 481.
34. R v Latimer [1997] 1 SCR 217.
35. Rock M. Discounted lives? Weighing disability when measuring health and ruling on "compassionate" murder. Soc Sci Med 2000;51:407-17.
36. Albright AL, Cervi A, Singletary J. Intrathecal Baclofen for spasticity in cerebral palsy. JAMA 1991;265:1418-23.
37. FDA peripheral and central nervous system drugs advisory committee. Medtronic intrathecal Baclofen receives approval of recommendation for treating refractory spasticity. FDC Reports Prescription and OTC Pharmaceutical 1991;53:9-11.
38. Albright AL, Barron WB, Fasick PM, et al. Continuous intrathecal Baclofen infusion for sposticity of cerebral origin. JAMA 1993;270:2475-8.
39. Koch T, Braun K, Pietsch J. Social necessity, individual rights, and the needs of the fragile: euthanasia in the context of end of life decision making. J Ethics Law Aging 1999;5:557-60.
40. Jansen A. The birth of bioethics: the origins of a demi-discipline. Med Humanit Rev 1997;2:9-21.
41. Tuner L. Bioethics, public health, and firearm-related violence: missing links between bioethics and public health. J Law Med Ethics 1997;25:42-8.
42. Neuland S. Doctors: the biography of medicine. New York: Vintage Books, 1989;ch 11.
43. Snow J. On the mode of the communication of cholera. [2nd ed]. London: Churchill, 1854.
44. Lewontin RC. Biology as ideology: the doctrine of DNA. NY: HarperCollins Books, 1993.
45. Equality and disability symposium. J Med Ethics 2001;27:361-92.
46. Crisp R, Hope T, Ebbs D. The Asbury draft policy on ethical use of resources. BMJ 1996;312:1528-33.
47. Thomasma DC. Commentary: guidelines for rationing resemble process of family decision making. 1996;312:1531-2.
48. Wolfe SM. Shifting paradigms in bioethics and health law: the rise of a new pragmatism. Am J Law Med 1994;20:395-415.